Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors

Since decades, lithium and valproate remain the pharmacological cornerstone to treat bipolar disorder. Different response patterns occur according to the phases of illness. At same time, individual pretreatment variables may concur to determine a specific drug-response. Our narrative review focuses...

Descripción completa

Detalles Bibliográficos
Autores principales: Crapanzano, Calogero, Casolaro, Ilaria, Amendola, Chiara, Damiani, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329114/
https://www.ncbi.nlm.nih.gov/pubmed/35879025
http://dx.doi.org/10.9758/cpn.2022.20.3.403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329114/
https://www.ncbi.nlm.nih.gov/pubmed/35879025
http://dx.doi.org/10.9758/cpn.2022.20.3.403

Ejemplares similares